| Key Financial Ratios of Dishman Pharmaceuticals & Chemicals (in Rs. Cr.) |
Mar 16 |
Mar 15 |
Mar 14 |
Mar 13 |
Mar 12 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
10.80 |
7.25 |
10.75 |
7.83 |
5.56 |
|
| Diluted EPS (Rs.) |
10.80 |
7.25 |
10.75 |
7.83 |
5.56 |
|
| Cash EPS (Rs.) |
16.28 |
12.72 |
16.22 |
12.21 |
9.48 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
112.74 |
103.44 |
98.57 |
89.68 |
83.43 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
112.95 |
103.65 |
98.77 |
89.89 |
83.64 |
|
| Dividend / Share(Rs.) |
2.00 |
2.00 |
1.20 |
1.20 |
1.20 |
|
| Revenue from Operations/Share (Rs.) |
63.25 |
59.32 |
58.65 |
60.06 |
57.42 |
|
| PBDIT/Share (Rs.) |
28.89 |
26.78 |
28.77 |
22.45 |
19.42 |
|
| PBIT/Share (Rs.) |
23.41 |
21.31 |
23.30 |
18.07 |
15.50 |
|
| PBT/Share (Rs.) |
14.90 |
12.87 |
14.73 |
11.74 |
8.37 |
|
| Net Profit/Share (Rs.) |
10.80 |
7.25 |
10.75 |
7.83 |
5.56 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
45.68 |
45.14 |
49.05 |
37.37 |
33.82 |
|
| PBIT Margin (%) |
37.01 |
35.92 |
39.73 |
30.08 |
26.98 |
|
| PBT Margin (%) |
23.56 |
21.68 |
25.10 |
19.54 |
14.57 |
|
| Net Profit Margin (%) |
17.07 |
12.21 |
18.33 |
13.03 |
9.67 |
|
| Return on Networth / Equity (%) |
9.57 |
7.00 |
10.91 |
8.72 |
6.65 |
|
| Return on Capital Employed (%) |
6.85 |
5.06 |
7.77 |
5.76 |
4.22 |
|
| Return on Assets (%) |
5.08 |
3.45 |
5.61 |
4.22 |
3.10 |
|
| Total Debt/Equity (X) |
0.60 |
0.61 |
0.52 |
0.63 |
0.64 |
|
| Asset Turnover Ratio (%) |
29.76 |
28.27 |
30.62 |
32.41 |
32.11 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.53 |
1.01 |
0.96 |
1.06 |
0.86 |
|
| Quick Ratio (X) |
1.20 |
0.69 |
0.65 |
0.74 |
0.54 |
|
| Inventory Turnover Ratio (X) |
3.51 |
2.78 |
3.54 |
3.79 |
3.89 |
|
| Dividend Payout Ratio (NP) (%) |
18.51 |
27.59 |
11.15 |
15.32 |
21.59 |
|
| Dividend Payout Ratio (CP) (%) |
12.28 |
15.72 |
7.39 |
9.82 |
12.65 |
|
| Earnings Retention Ratio (%) |
81.49 |
72.41 |
88.85 |
84.68 |
78.41 |
|
| Cash Earnings Retention Ratio (%) |
87.72 |
84.28 |
92.61 |
90.18 |
87.35 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
3,243.55 |
1,830.17 |
1,079.83 |
1,005.76 |
793.24 |
|
| EV/Net Operating Revenue (X) |
6.36 |
3.82 |
2.28 |
2.08 |
1.71 |
|
| EV/EBITDA (X) |
13.91 |
8.47 |
4.65 |
5.55 |
5.06 |
|
| MarketCap/Net Operating Revenue (X) |
5.31 |
2.81 |
1.43 |
1.15 |
0.80 |
|
| Retention Ratios (%) |
81.48 |
72.40 |
88.84 |
84.67 |
78.40 |
|
| Price/BV (X) |
2.98 |
1.61 |
0.85 |
0.77 |
0.55 |
|
| Price/Net Operating Revenue |
5.31 |
2.81 |
1.43 |
1.15 |
0.80 |
|
| Earnings Yield |
0.03 |
0.04 |
0.13 |
0.11 |
0.12 |
|
Source : Dion Global Solutions Limited
